Transderm Scop®

DRUG2 trials

Sponsors

University of Iowa, Repurposed Therapeutics, Inc.

Conditions

HealthyMotion Sickness

Phase 2

DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness

TerminatedNCT04219982

Repurposed Therapeutics, Inc.Motion Sickness

Start: 2018-06-29End: 2019-01-28Updated: 2020-01-07

Phase 4

Scopolamine Patch Pharmacokinetics in Healthy Adults

CompletedNCT03029650

University of IowaHealthy

Start: 2016-11-30End: 2018-03-31Updated: 2018-06-21